Document is current
Any future updates will be listed below
-
Authors
,
Fehr, Martin https://orcid.org/0000-0003-2128-9061
,
,
,
Hawle, Hanne
Hayoz, Stefanie
Thuss-Patience, Peter
Schacher, Sabina
Riera Knorrenschild, Jorge
Dürr, Donat
Knoefel, Wolfram T.
Rumpold, Holger
Bitzer, Michael
Zweifel, Martin
Samaras, Panagiotis
Mey, Ulrich
Küng, Marc
Winterhalder, Ralph
Eisterer, Wolfgang
Hess, Viviane
Gérard, Marie-Aline
Templeton, Arnoud
Stahl, Michael
Ruhstaller, Thomas
-
Funding
Funding for this research was provided by:
Staatssekretariat für Bildung, Forschung und Innovation (No grant number applies)
Merck KGaA, Darmstadt, Germany (No grant numer applies)
- License Information
-
More Information
Article History
Received: 13 October 2019
Accepted: 11 February 2020
First Online: 28 February 2020
Ethics approval and consent to participate
: The ethical committees (EC) for the approval of the trial (with reference numbers were applicable) were as follows, Tables and :In Germany the ECs for the respective institutions were as in Table :The trial was registered at EU Clinical Trials Register (EudraCT- Nr: 2009–016584-10) and under NCT01107639.All patients gave their written consent for participation in this trial.
: Not applicable.
: Co-author Thomas Ruhstaller is an Associate Editor of this journal. All other authors declare that they have no competing interests.
